113 related articles for article (PubMed ID: 35818932)
1. Inhibition of Mitochondrial Biosynthesis Using a "Right-Side-Out" Membrane-Camouflaged Micelle to Facilitate the Therapeutic Effects of Shikonin on Triple-Negative Breast Cancer.
Peng J; Hu X; Fan S; Zhou J; Ren S; Sun R; Chen Y; Shen X; Chen Y
Adv Healthc Mater; 2022 Sep; 11(18):e2200742. PubMed ID: 35818932
[TBL] [Abstract][Full Text] [Related]
2. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Targeting Micelles Based on Linear-Dendritic PEG-PTX
Zhang Y; Lu Y; Zhang Y; He X; Chen Q; Liu L; Chen X; Ruan C; Sun T; Jiang C
Mol Pharm; 2017 Oct; 14(10):3409-3421. PubMed ID: 28832164
[TBL] [Abstract][Full Text] [Related]
4. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
5. Codelivery of Shikonin and siTGF-β for enhanced triple negative breast cancer chemo-immunotherapy.
Li J; Zhao M; Liang W; Wu S; Wang Z; Wang D
J Control Release; 2022 Feb; 342():308-320. PubMed ID: 35031387
[TBL] [Abstract][Full Text] [Related]
6. A modified natural small molecule inhibits triple-negative breast cancer growth by interacting with Tubb3.
Han H; Yang M; Wen Z; Wang X; Lai X; Zhang Y; Fang R; Yin T; Yang X; Wang X; Zhao Q; Qi J; Chen H; Lin H; Yang Y
Phytomedicine; 2024 Apr; 126():154894. PubMed ID: 38377719
[TBL] [Abstract][Full Text] [Related]
7. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
8. A novel redox/pH dual-responsive and hyaluronic acid-decorated multifunctional magnetic complex micelle for targeted gambogic acid delivery for the treatment of triple negative breast cancer.
Sang MM; Liu FL; Wang Y; Luo RJ; Huan XX; Han LF; Zhang ZT; Feng F; Qu W; Liu W; Zheng F
Drug Deliv; 2018 Nov; 25(1):1846-1857. PubMed ID: 30334478
[TBL] [Abstract][Full Text] [Related]
9. Tailored-CuO-nanowire decorated with folic acid mediated coupling of the mitochondrial-ROS generation and miR425-PTEN axis in furnishing potent anti-cancer activity in human triple negative breast carcinoma cells.
Ahir M; Bhattacharya S; Karmakar S; Mukhopadhyay A; Mukherjee S; Ghosh S; Chattopadhyay S; Patra P; Adhikary A
Biomaterials; 2016 Jan; 76():115-32. PubMed ID: 26520043
[TBL] [Abstract][Full Text] [Related]
10. Shikonin is a novel and selective IMPDH2 inhibitor that target triple-negative breast cancer.
Wang W; Wu Y; Chen S; Liu X; He J; Wang S; Lu W; Tang Y; Huang J
Phytother Res; 2021 Jan; 35(1):463-476. PubMed ID: 32779300
[TBL] [Abstract][Full Text] [Related]
11. Engineered Red Blood Cell Membrane-Coating Salidroside/Indocyanine Green Nanovesicles for High-Efficiency Hypoxic Targeting Phototherapy of Triple-Negative Breast Cancer.
Pan Y; He Y; Zhao X; Pan Y; Meng X; Lv Z; Hu Z; Mou X; Cai Y
Adv Healthc Mater; 2022 Sep; 11(17):e2200962. PubMed ID: 35735086
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction.
Coleman MF; O'Flanagan CH; Pfeil AJ; Chen X; Pearce JB; Sumner S; Krupenko SA; Hursting SD
Nutrients; 2021 May; 13(5):. PubMed ID: 34068120
[TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
14. Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis.
Li C; Wang Z; Zhang Y; Zhu Y; Xu M; Lei H; Zhang D
Int J Nanomedicine; 2024; 19():1749-1766. PubMed ID: 38414527
[TBL] [Abstract][Full Text] [Related]
15. Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
Lee JS; Oh Y; Lee JS; Park JH; Shin JK; Han JH; Kim HS; Yoon S
In Vivo; 2022; 36(5):2105-2115. PubMed ID: 36099094
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoids nano-micelles for the management of triple negative breast cancer.
Greish K; Mathur A; Al Zahrani R; Elkaissi S; Al Jishi M; Nazzal O; Taha S; Pittalà V; Taurin S
J Control Release; 2018 Dec; 291():184-195. PubMed ID: 30367922
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance.
Cui H; Huan ML; Ye WL; Liu DZ; Teng ZH; Mei QB; Zhou SY
Mol Pharm; 2017 Mar; 14(3):746-756. PubMed ID: 28146635
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted high-load sound-sensitive micelles for sonodynamic therapy to treat triple-negative breast cancer and inhibit metastasis.
Han X; Song Z; Zhou Y; Zhang Y; Deng Y; Qin J; Zhang T; Jiang Z
Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112054. PubMed ID: 33947548
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer.
Lee SY; Cho HJ
Biomacromolecules; 2019 Feb; 20(2):835-845. PubMed ID: 30566834
[TBL] [Abstract][Full Text] [Related]
20. Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle.
Su Y; Huang N; Chen D; Zhang L; Dong X; Sun Y; Zhu X; Zhang F; Gao J; Wang Y; Fan K; Lo P; Li W; Ling C
Int J Nanomedicine; 2017; 12():4019-4035. PubMed ID: 28603416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
